Medpace CEO Sells 4,673 Shares, Nets Nearly $2.9 Million

According to a recent filing with the U.S. Securities and Exchange Commission, Medpace Holdings President and CEO August J Troendle disclosed an insider sale on August 27.

Event details: Per a Form 4 filing submitted to the SEC on Thursday, Troendle decided to sell 4,673 shares of Medpace Holdings stock. The total value of the transaction was $2,897,635.

Medpace Holdings shares were trading at $611.57 in Friday's early session, down 0.97%.

A Closer Look at Medpace Holdings

Medpace is a late-stage contract research organization that provides full-cycle drug development and clinical trial services to small and mid-sized biotechnology, pharmaceutical, and medical device companies. The company also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. Founded over 30 years ago, the company employs more than 5,400 staff across 40 countries. Medpace is headquartered in Cincinnati, Ohio, with operations primarily concentrated in the U.S., along with a presence in Europe, Asia, South America, Africa, and Australia. Global private equity firm Cinven acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Interpreting Medpace Holdings' Financial Position

Revenue growth: Medpace Holdings posted positive results over a three-month period. As of June 30, 2026, the company achieved a solid revenue growth rate of approximately 17.24%. This indicates significant top-line expansion. Compared to peers, the company's growth rate exceeds the average among healthcare sector counterparts.

Profitability metrics:

Gross margin: The company's gross margin is low at 28.51%, indicating below-average profitability and suggesting potential cost efficiency challenges relative to industry peers.

Earnings per share: Medpace Holdings' EPS stands out, reflecting a positive earnings trend, with a current EPS of 4.31, surpassing the industry average.

Debt management: Medpace Holdings has a below-average debt-to-equity ratio of 0.28, reflecting a prudent financial strategy and indicating a balanced approach to debt management.

Financial valuation analysis:

P/E ratio: The current P/E ratio of 35.89 is below the industry norm, suggesting potential undervaluation and presenting an investment opportunity.

P/S ratio: A price-to-sales ratio of 6.33 is below industry standards, indicating the stock may be undervalued and representing an attractive option for investors focused on sales performance.

EV/EBITDA analysis: The company's EV/EBITDA multiple of 27.27 is below the industry average, suggesting its valuation may be relatively low compared to peers.

Market cap analysis: The company's market capitalization is below the industry average, reflecting its smaller scale. This could be attributed to factors such as growth expectations or operational capacity.

Exploring the Significance of Insider Transactions

While insider transactions can be insightful, they should be considered alongside a comprehensive review of other investment criteria.

Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than 10% of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes top management executives and large hedge funds. These insiders must disclose their transactions via Form 4 filings within two business days of the transaction.

New purchases initiated by company insiders strongly signal their expectation that the stock will rise.

However, insider selling does not always imply a bearish view and may be influenced by a variety of factors.

Key Transaction Codes

For investors, the primary focus is on transactions occurring in the open market, as shown in Table I of Form 4 filings. A "P" in column 3 indicates a purchase, while an "S" indicates a sale. Transaction code "C" denotes a conversion of options, and transaction code "A" signifies an acquisition from the company, such as a grant, award, or other securities.

View the full list of Medpace Holdings insider transactions.

This article was generated by an automated content engine and reviewed by an editor.